The reproducibility of the expression of these two miRNAs was further verified in the blood plasma of an independent test cohort of AD patients and controls, as well as in the brain parenchyma of 6-month-old APP/PS1 mice and C57BL/6J control mice. This evidence concerns the gene APP and Alzheimer disease.